03/27/2024
4:47 PM | Davis Todd C (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
12:27 PM | Ligand Pharmaceuticals (Issuer)
Sabba Stephen L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
4:28 PM | Aryeh Jason (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
5:12 PM | Ligand Pharmaceuticals (Subject)
Sabba Stephen L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
5:49 PM | Davis Todd C (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
5:50 PM | Espinoza Octavio (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
5:50 PM | Korenberg Matthew E (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
02/29/2024
5:50 PM | Ligand Pharmaceuticals (Issuer)
Reardon Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:49 PM | Espinoza Octavio (Reporting)
Ligand Pharmaceuticals (Subject)
| Form 144/A | |
02/29/2024
3:16 PM | Ligand Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/28/2024
5:05 PM | Gray Nancy Ryan (Reporting)
Ligand Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024
4:43 PM | Espinoza Octavio (Reporting)
Ligand Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024
6:24 AM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/16/2024
7:10 PM | Davis Todd C (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
7:10 PM | Espinoza Octavio (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
7:10 PM | Korenberg Matthew E (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
7:10 PM | Ligand Pharmaceuticals (Issuer)
Reardon Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
5:26 AM | Ligand Pharmaceuticals (Subject)
MACQUARIE GROUP LTD (Filed by)
| Form SC 13G | |
02/13/2024
2:39 PM | JANUS HENDERSON GROUP PLC (Filed by)
Ligand Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/12/2024
6:42 PM | GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Ligand Pharmaceuticals (Subject)
| Form SC 13G | |
01/22/2024
1:03 PM | BlackRock Inc. (Filed by)
Ligand Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/04/2024
3:07 PM | Korenberg Matthew E (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:07 PM | Ligand Pharmaceuticals (Issuer)
Reardon Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2023
2:27 PM | Korenberg Matthew E (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2023
2:27 PM | Espinoza Octavio (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
7:25 AM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/18/2023
8:03 AM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2023
3:36 PM | Espinoza Octavio (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2023
7:38 AM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2023
3:41 PM | Ligand Pharmaceuticals (Issuer)
Zimmermann Martine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2023
5:12 PM | Ligand Pharmaceuticals (Issuer)
Zimmermann Martine (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/25/2023
3:44 PM | Davis Todd C (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2023
4:26 PM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
3:20 PM | Ligand Pharmaceuticals (Issuer)
Reardon Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2023
5:42 PM | Espinoza Octavio (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2023
5:42 PM | Korenberg Matthew E (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
8:28 AM | Ligand Pharmaceuticals (Issuer)
Sabba Stephen L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
5:52 PM | Davis Todd C (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
5:53 PM | Haas Jason (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
5:54 PM | Aryeh Jason (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
5:54 PM | KOZARICH JOHN W (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad) 4x Better than Bitcoin
Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> |
06/13/2023
5:55 PM | LAMATTINA JOHN L (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
5:55 PM | Gray Nancy Ryan (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/18/2023
4:18 PM | KOZARICH JOHN W (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/12/2023
2:43 PM | Ligand Pharmaceuticals (Issuer)
Sabba Stephen L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2023
6:07 PM | Ligand Pharmaceuticals (Subject)
Sabba Stephen L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/10/2023
6:15 PM | KOZARICH JOHN W (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2023
3:06 PM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
